Peter Hoffmann

Pharmidex

Pharmidex provides translational solutions using its world renowned expertise in CNS/Oncology, drug discovery and ADMET/PK. Founded in the UK in 2002, Pharmidex operates in state-of-the-art facilities in London and Hatfield to provide high quality bespoke experimental data to support drug discovery & development. The industry expertise within Pharmidex and its dynamic client interaction delivers a high level of customer satisfaction and has been the key in forming strategic international alliances. Key areas of expertise are: in-vitro & in-life ADMET, Pharmacology, CNS/Oncology/Respiratory, Drug Discovery, Bioanalysis, Metabolite Identification, Bioimaging and toxicology. Pharmidex has a global list of clients that includes major Pharma, biotechs, governmental institutes, universities and medical charities. We have experience working with clients based in North America, Europe and Japan as well as other territories. Pharmidex has also extensive experience and success in grant funded research collaborations.